Enolase Antibodies

Santa Cruz Biotechnology features a diverse variety of Enolase monoclonal antibodies for investigating enolase in various biological processes. Enolase monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Enolase is a key enzyme in the glycolytic pathway, catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Enolase functions as an essential component in energy production and metabolism, making it critical for cellular function and survival. Research has shown that enolase expression levels can influence tumor progression and response to therapy in various cancers. Scientists studying metabolic disorders frequently utilize enolase monoclonal antibodies to explore cellular energy mechanisms. Researchers investigating cancer biology often incorporate enolase monoclonal antibodies to examine metabolic alterations in tumor cells. Understanding enolase activity patterns helps reveal new therapeutic approaches for metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies for enolase research enable scientists to advance our understanding of cellular metabolism and disease mechanisms.